US Stock MarketDetailed Quotes
VIGL Vigil Neuroscience
- 2.610
- +0.010+0.38%
Close Apr 30 16:00 ET
- 2.610
- 0.0000.00%
Post 16:20 ET
98.10MMarket Cap-1225P/E (TTM)
2.660High2.545Low39.20KVolume2.600Open2.600Pre Close102.25KTurnover0.23%Turnover RatioLossP/E (Static)37.58MShares11.11052wk High0.84P/B44.17MFloat Cap2.50052wk Low--Dividend TTM16.92MShs Float18.270Historical High--Div YieldTTM4.42%Amplitude2.180Historical Low2.608Avg Price1Lot Size
Vigil Neuroscience Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.00%-70.36M | 9.23%-15.51M | -8.72%-17.31M | -9.72%-15.35M | -22.28%-22.19M | -65.58%-65.15M | 1.50%-17.09M | -43.82%-15.93M | -127.01%-13.99M | -280.94%-18.14M |
| Net income from continuing operations | -20.98%-82.64M | -20.15%-22.17M | -17.11%-20.5M | -18.57%-20.17M | -29.09%-19.8M | -57.81%-68.31M | -42.13%-18.46M | -62.94%-17.5M | -49.69%-17.02M | -87.21%-15.33M |
| Operating gains losses | ---8K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 411.54%399K | 438.10%113K | 423.81%110K | 516.67%111K | 261.11%65K | 178.57%78K | 40.00%21K | 75.00%21K | 1,700.00%18K | --18K |
| Other non cash items | 46.35%1.36M | 34.78%341K | 47.41%342K | 59.21%363K | 45.21%318K | -21.08%932K | 48.82%253K | 41.46%232K | -60.28%228K | -19.78%219K |
| Change In working capital | 193.01%3.1M | 947.54%3.44M | 725.00%1.08M | 116.43%2.85M | -4.82%-4.26M | -618.85%-3.33M | 92.35%-406K | 83.85%-172K | -68.65%1.32M | -244.15%-4.07M |
| -Change in prepaid assets | 213.67%4.18M | 190.10%2.24M | 32.57%-648K | 182.18%2.12M | 147.72%471K | 25.17%-3.68M | 48.39%-2.48M | -24.64%-961K | 327.27%752K | -301.43%-987K |
| -Change in payables and accrued expense | -124.98%-379K | -37.87%1.49M | -3.93%1.91M | 6,806.25%1.07M | -70.25%-4.85M | -74.49%1.52M | 943.31%2.4M | 1,372.44%1.99M | -100.39%-16K | -222.08%-2.85M |
| -Change in other current assets | 67.95%-83K | 1.19%-83K | --0 | --0 | --0 | -338.98%-259K | -95.35%-84K | -4,690.48%-964K | --805K | ---16K |
| -Change in other current liabilities | 31.46%-623K | 13.30%-202K | 20.69%-184K | -54.42%-349K | 151.38%112K | -177.13%-909K | -37.87%-233K | -45.91%-232K | ---226K | ---218K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.00%-70.36M | 9.23%-15.51M | -8.72%-17.31M | -9.72%-15.35M | -22.28%-22.19M | -65.58%-65.15M | 1.50%-17.09M | -43.82%-15.93M | -127.01%-13.99M | -280.94%-18.14M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -6,972.53%-65.14M | 4,017.28%10.66M | 3,781.25%15.31M | -24,189.01%-22.1M | -48,494.37%-69M | -351.47%-921K | -907.41%-272K | -288.79%-416K | -30.00%-91K | -142K |
| Net PPE purchase and sale | 26.82%-674K | 95.22%-13K | 88.70%-47K | -34.07%-122K | -246.48%-492K | -351.47%-921K | -907.41%-272K | -288.79%-416K | -30.00%-91K | ---142K |
| Net investment purchase and sale | ---64.46M | --10.67M | --15.36M | ---21.98M | ---68.51M | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -6,972.53%-65.14M | 4,017.28%10.66M | 3,781.25%15.31M | -24,189.01%-22.1M | -48,494.37%-69M | -351.47%-921K | -907.41%-272K | -288.79%-416K | -30.00%-91K | ---142K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.45%888K | -47.52%53K | -99.93%53K | 276.52%579K | -99.77%203K | 49.66%161.26M | 105.42%101K | -20.53%71.29M | -101.65%-328K | 90.19M |
| Net issuance payments of debt | 46.51%-23K | --0 | 81.82%-2K | 9.09%-10K | -10.00%-11K | -13.16%-43K | -10.00%-11K | -37.50%-11K | 45.00%-11K | ---10K |
| Net common stock issuance | --0 | --0 | --0 | --0 | --0 | --140.47M | ---8K | --50.6M | ---319K | --90.19M |
| Proceeds from stock option exercised by employees | -95.63%911K | -55.83%53K | -99.73%55K | 29,350.00%589K | 2,277.78%214K | 54,721.05%20.83M | 215.79%120K | --20.7M | --2K | --9K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.45%888K | -47.52%53K | -99.93%53K | 276.52%579K | -99.77%203K | 49.66%161.26M | 105.42%101K | -20.53%71.29M | -101.65%-328K | --90.19M |
| Net cash flow | ||||||||||
| Beginning cash position | 103.07%187.53M | -71.81%57.72M | -60.18%59.67M | -41.22%96.55M | 103.07%187.53M | 282.37%92.35M | 83.53%204.79M | 353.25%149.84M | 747.18%164.25M | 282.37%92.35M |
| Current changes in cash | -241.42%-134.61M | 72.18%-4.8M | -103.54%-1.95M | -155.88%-36.88M | -226.54%-90.99M | 39.58%95.19M | 10.28%-17.26M | -30.02%54.95M | -205.42%-14.41M | 1,609.64%71.9M |
| End cash Position | -71.78%52.92M | -71.78%52.92M | -71.81%57.72M | -60.18%59.67M | -41.22%96.55M | 103.07%187.53M | 103.07%187.53M | 83.53%204.79M | 353.25%149.84M | 747.18%164.25M |
| Free cash flow | -7.52%-71.04M | 10.58%-15.52M | -6.24%-17.36M | -9.88%-15.48M | -24.02%-22.68M | -67.05%-66.07M | 0.09%-17.36M | -46.16%-16.34M | -125.92%-14.08M | -283.92%-18.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg